Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. (2019)

First Author: Joharatnam-Hogan N
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(19)30289-4

PubMed Identifier: 31477558

Publication URI: http://europepmc.org/abstract/MED/31477558

Type: Journal Article/Review

Volume: 4

Parent Publication: The lancet. Gastroenterology & hepatology

Issue: 11